Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.
about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersCost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysisCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsThe cost-effectiveness of total joint arthroplasty: a systematic review of published literatureTwenty years of cost-effectiveness analysis in medical imaging: are we improving?The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trialsGlobal Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic ReviewCost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonanceThe quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic reviewCan delivery systems use cost-effectiveness analysis to reduce healthcare costs and improve value?Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantationCost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange programPulmonary impairment after tuberculosis and its contribution to TB burdenYoga vs. physical therapy vs. education for chronic low back pain in predominantly minority populations: study protocol for a randomized controlled trial.Routine HIV screening in France: clinical impact and cost-effectivenessInternational lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines.The economic burden of incisional ventral hernia repair: a multicentric cost analysis.Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.Can economic evaluation in telemedicine be trusted? A systematic review of the literature.The value of health care--a matter of discussion in Germany.Cost-effectiveness of testing for human immunodeficiency virus and hepatitis C virus among blood transfusion recipients.Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of dementia screening (CHOICE) study: study protocol for a randomized controlled trial.Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model.Evaluating eHealth: undertaking robust international cross-cultural eHealth research.Patient time requirements for anticoagulation therapy with warfarin.Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysisCost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.Comparison of complementary and alternative medicine with conventional mind-body therapies for chronic back pain: protocol for the Mind-body Approaches to Pain (MAP) randomized controlled trial.Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic AnalysisDynamic Assessment of Value During High-Cost Cancer Treatment: A Response to American Society of Clinical Oncology and European Society of Medical Oncology.Evaluating the benefits of increasing measles immunization ratesPharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic reviewSetting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.Economic evaluation and transferability of physical activity programmes in primary prevention: a systematic review.Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysisCost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors.
P2860
Q22330767-2C7D980E-EDE1-4922-9BBC-65AAE9193425Q24554238-BC69BEC5-C1AE-4D25-A653-8E38356D853DQ24614627-68937FB4-954C-469D-8512-76275D33A1A7Q24622561-0B562C4E-7A97-4A4F-BC3A-F188F65C72E4Q24650469-0C756386-A528-4FE0-80F6-FCA075530A49Q24799154-E057C1B4-C30F-4E5D-9252-D2C81441C51FQ26766870-4FBE3EF8-5F4E-4F19-B0FD-5E19E18C206EQ26865761-25EBDFBB-9B99-4ECF-A013-160FC5DBB40EQ28073282-E08F5312-769F-4232-845B-0536FC2C9F57Q28076477-8BD89ADA-B564-4B9A-B00E-158C1F8509F3Q28344370-86217905-831F-4D5B-B721-41C27E2ADC0EQ28359547-BCEE3F56-253C-4A9A-99DD-F47354903041Q28396542-0A7D3842-0929-4282-A900-766B722AF840Q28397024-6A8E6686-24F9-4C01-82C5-4BF229121FCAQ28475837-C03AB269-17BB-4439-9A95-28F9BCCA7BDCQ30235933-22D1EC94-7AC2-404D-AFF9-D6E23F512ADFQ30251852-BFF38E28-99BC-4D89-9F36-E5862448BDF7Q30275646-C57C912E-4535-4B3C-94BA-140AB743A965Q30491297-28946FED-0B43-4333-8984-ECC52F3F6235Q30828900-63EC1F3C-9617-40B9-BD4F-23FE4227068BQ31132856-E9B8C765-CCF6-4AE4-9799-A928FA4D104CQ33178455-A4183130-D93F-41D0-90D8-6CC0E6E92D86Q33395099-CA5FD1A2-389A-4907-8239-69C90858F2FFQ33419430-D22F4E86-44D0-4637-A49B-8AEAB5CDAB18Q33441704-FF55560D-5519-4C9E-95FA-A52031F0D006Q33503211-047B25D9-8044-4B2C-9929-4777C5999952Q33505924-0D4230AE-9659-4D82-9F2A-EDFA308B1025Q33568561-F675E7F6-B38B-49E0-A2C1-7AA8929AAD56Q33598247-66299692-5FC8-4ED2-A707-16DA13431BA9Q33605199-5D616678-66A1-4D0D-9784-42E161FE37CEQ33736626-9DBE9725-6087-4A52-AA24-B81EA0BEC140Q33737122-5D007226-8299-429C-AE12-5DE5E18E8316Q33756769-BAEEBA47-37F8-4779-8DFD-9F6EDE342621Q33774235-FECB054C-DFF2-4A26-813C-DD2C0760E53FQ33782365-341B4BAE-62EB-4269-8C93-BCEB081A8C01Q33804561-DB6C4A1A-39BB-418E-BFC6-6925A4B69828Q33851741-D7A7B8DA-46FE-43DC-A809-2D14BF5E7730Q33859085-E80543A1-D28A-4C6B-B1D6-3A6B9F394BA5Q33871791-230AD85E-BD23-4F2F-9CD4-C3EBC2FD3B33Q33872813-A2C88082-89FD-44C0-83A7-6872B5D68F71
P2860
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Recommendations for reporting ...... veness in Health and Medicine.
@en
type
label
Recommendations for reporting ...... veness in Health and Medicine.
@en
prefLabel
Recommendations for reporting ...... veness in Health and Medicine.
@en
P2093
P1476
Recommendations for reporting ...... veness in Health and Medicine.
@en
P2093
J E Siegel
L B Russell
M C Weinstein
P304
P356
10.1001/JAMA.1996.03540160061034
P407
P577
1996-10-01T00:00:00Z